Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-22

Clinical Trial Update: BIP Foley in Prevention of CAUTI at Rehab Station [Phase 4]

View source ↗

Summary

Phase 4 trial update on BIP Foley for prevention of catheter-associated urinary tract infection (CAUTI) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BIP Foley

Snippet

Sponsor: Bactiguard AB | Conditions: Complications; Catheter, Urinary Infection or Inflammation | Phase 4 | Status: COMPLETED